Inorganic Chemistry
Article
residual solvent signals for 1H and 13C NMR (1H NMR: 7.26 ppm for
CDCl3, 3.34 ppm for CD3OD, 1.94 ppm for CD3CN, 2.50 ppm for
DMSO; 13C NMR: 77.0 ppm for CDCl3, 48.9 ppm for CD3OD, 1.32
ppm for CD3CN, 39.5 ppm for DMSO). 19F NMR spectra were
recorded at 376.25 MHz or at 564.3 MHz using trichlorofluor-
ometane as external standard. 13C NMR spectra were acquired with
1H broad band decoupled mode. Coupling constants are given in
Hertz. The high-resolution mass spectra (HRMS) were obtained with
a Waters Q-TOF-MS instrument using electrospray ionization (ESI).
General Procedures. 2-(1-Benzyl-1H-1,2,3-triazol-4-yl) pyridine
9a,49 2-(1-phenyl-1H-1,2,3-triazol-4-yl) pyridine 9b,49 1,1′-dibenzyl-
1H,1′H-4,4′-bi(1,2,3-triazole) 9c,10 1-benzyl-3-methyl-4-(pyridin-2-
yl)-1H-1,2,3-triazol-3-ium trifluoromethanesulfonate 10a-OTf,33
1,1′-dibenzyl-3-methyl-4,4′-bis(1H-1,2,3-triazol)-3-ium iodide 10c-
I50 were prepared according to reported methods.
MHz) δ: 151.3 (CH), 144.0 (C), 142.7 (C), 139.3 (CH), 136.0 (C),
133.1 (CH), 131.6 (CH), 128.4 (CH), 127.1 (CH), 125.8 (CH),
122.6 (CH), 42.1 (CH3). HRMS (ESI-QTOF) ([M]+): m/z calcd for
[C14H13N4]+ 237,1135; found: 237.1138 and 11b-I (444 mg, 1.22
1
mmol, 61% yields) H NMR (600 MHz, CD3CN) δ: 4.56 (s, 3H),
7.60−7.65 (m, 1H), 7.65−7.70 (m, 2H), 8.00−8.05 (m, 3H), 8.55−
8.60 (m, 2H), 8.85 (d, 1H, JHH = 6.3 Hz), 9.27 (s, 1H). 13C NMR
(100 MHz, D6-DMSO) δ: 147.4 (CH), 145.3 (CH), 145.2 (C),
139.1 (C), 135.9 (C), 130.1 (CH), 129.8 (CH), 128.1 (CH), 127.0
(CH), 126.6 (CH), 120.8 (CH), 48.6 (CH3). HRMS (ESI-QTOF)
([M]+): m/z calcd for [C14H13N4]+ 237,1135; found: 237.1139.
General Procedure for the Synthesis of Complexes 1-BF4
and 2-BF4 from 1H-1,2,3-Triazol-3-ium Triflates. The desired
1H-1,2,3-triazol-3-ium triflate (0.08 mmol) was dissolved in ACN (6
mL), and then KCl (0.80 mmol, 10 equiv) and Ag2O (0.28 mmol, 3.5
equiv) were added. The resulting mixture was stirred under N2 at
room temperature in the absence of light. After 24 h, the formed solid
was filtered off and washed with ACN (10 mL). The resulting
solution was then concentrated under reduced pressure to give a
white solid that was dissolved in DCM/EtOH = 3/1 (8 mL), and
[Ir(ppy)2Cl]2 (0.04 mmol, 0.5 equiv) was added. After the solution
was stirred for 24 h at room temperature, the solvent was evaporated,
and the crude reaction mixture was purified by column chromatog-
raphy to give the expected Ir-complex as triflate salt that was dissolved
in DCM/EtOH = 5/1 (12 mL). Then, NH4BF4 (40 equiv) was
added. The resulting mixture was stirred at rt for 2 h; water (10 mL)
was added, and the product was extracted with DCM (2 × 10 mL).
The organic layer was dried over Na2SO4 and the solvent evaporated.
The obtained solid was dissolved in a minimum amount of DCM,
precipitated by Et2O addition, and filtered to give Ir-complex as
tetrafluoroborate salt.
Caution: Although we experienced no difficulties in handling these
nitrogen-rich compounds, small scale and best safety practices are
strongly encouraged.
Synthesis of 1-Benzyl-3-methyl-4-(pyridin-2-yl)-1H-1,2,3-triazol-
3-ium Iodide 10a-I and 2-(1-Benzyl-1H-1,2,3-triazol-4-yl)-1-meth-
ylpyridin-1-ium Iodide 11a-I. 2-(1-Benzyl-1H-1,2,3-triazol-4-yl)
pyridine 9a (472 mg, 2.00 mmol) was dissolved in anhydrous ACN
(12 mL), and MeI (0.624 mL, 10.0 mmol, 5 equiv) was added. The
solution was refluxed for 24 h under N2. Then, the solvent was
removed and the crude was purified by column cromatography on
silica gel with DCM/MeOH as eluent, from 95/5 to 7/3 ratio, to give
10a-I (98 mg, 0.26 mmol, 13% yields). 1H NMR (300 MHz,
CD3OD) δ: 4.64 (s, 3H), 5.91 (s, 2H), 7.45−7.50 (m, 3H), 7.55−
7.65 (m, 3H), 7.95−8.10 (m, 2H), 8.81 (bd, 1H, JHH = 5.0 Hz), 9.32
(s, 1H). 13C NMR, (CD3OD, 100 MHz) δ: 151.1 (CH), 144.3 (C),
142.4 (C), 139.1 (CH), 133.2 (C), 130.7 (CH), 130.3 (CH), 130.3
(CH), 129.9 (CH), 126.8 (CH), 125.6 (CH), 58.4 (CH2), 41.6
(CH3). HRMS (ESI-QTOF) ([M]+): m/z calcd for [C15H15N4]+
251.1291; found 251.1295 and 11a-I (537 mg, 1.42 mmol, 71%
General Procedure for the Synthesis of the Complexes
from 1H-1,2,3-Triazol-3-ium Iodides. The desired 1H-1,2,3-
triazol-3-ium iodide (0.06 mmol) was dissolved in DCM (15 mL),
and Ag2O (0.15 mmol, 2.6 equiv) was added. The resulting mixture
was stirred under N2 at room temperature in the absence of light.
After 2 h, [Ir(ppy)2Cl]2 (0.03 mmol, 0.5 equiv) was added, and the
mixture was stirred for additional 24 h at room temperature under N2
in the absence of light. Then, the solid was filtered off, washed with
DCM (25 mL), and the combined solutions were concentrated under
reduced pressure. The crude product was purified by column
chromatography to give the expected Ir-complex as iodide salt that
was dissolved in DCM/EtOH = 5/1 (20 mL), and NH4BF4 (40
equiv) was added. The resulting mixture was stirred at rt for 48 h;
water (15 mL) was added, and the product was extracted with DCM
(2 × 20 mL). The organic layer was dried over Na2SO4 and the
solvent evaporated. The obtained solid was dissolved in a minimum
amount of DCM, precipitated by Et2O addition and filtered to give Ir-
complex as tetrafluoroborate salt.
1
yields) H NMR (600 MHz, CD3CN) δ: 4.45 (s, 3H), 5.76 (s, 2H),
7.35−7.50 (m, 5H), 7.94 (bt, 1H, JHH = 7.0), 8.43 (dd, 1H, JHH = 8.3
Hz, JHH = 1.1 Hz), 8.51 (bt, 1H, JHH = 7.9 Hz), 8.79 (d, 1H, JHH = 6.3
Hz), 8.87 (s, 1H). 13C NMR (125 MHz, CD3CN) δ: 49.4 (CH3),
55.0 (CH2), 127.4 (CH), 129.4 (CH), 129.5 (CH), 129.6 (CH),
129.7 (CH), 130.0 (CH), 135.9 (C), 139.5 (C), 146.3 (CH), 147.3
(C), 147.8 (CH). HRMS (ESI-QTOF) ([M]+): m/z calcd for
[C15H15N4]+ 251.1291; found 251.1294.
Synthesis of 1-Phenyl-3-methyl-4-(pyridin-2-yl)-1H-1,2,3-triazol-
3-ium Trifluoromethanesulfonate 10b-OTf. 2-(1-Phenyl-1H-1,2,3-
triazol-4-yl) pyridine 9b (460 mg, 2.07 mmol) was dissolved in
anhydrous DCM (10 mL), and MeOTf (0.28 mL, 2.48 mmol, 1.2
equiv) was added dropwise. The solution was refluxed for 24 under
N2; the solvent was removed, and and the crude was purified by
column chromatography on silica gel (DCM/MeOH = 95/5) to give
10b-OTf (432 mg, 1.1 mmol, 54% yields. 1H NMR (400 MHz,
CDCl3) δ 10.07 (s, 1H), 8.74 (dq, JHH = 0.8, JHH = 4.8, 1H), 8.40 (dt,
−
[Ir(ppy)2(ptb)]+BF4 (1-BF4). From triazolium triflate 10a-OTf 44
mg, 0.053 mmol yields = 66%. From triazolium iodide 10a-I 25 mg,
1
0.029 mmol yields = 49%. H NMR (600 MHz, CDCl3) δ: 4.67 (s,
J
HH = 0.8, JHH = 8.0, 1H), 8.11−8.07 (m, 2H), 7.92 (dt, JHH = 2.0, JHH
3H), 4.90−4.97 (AB system, 2H), 6.25 (d, 1H, JHH = 7.4 Hz), 6.33
(d, 1H, JHH = 7.7 Hz), 6.55 (d, 2H, JHH = 7.6 Hz), 6.82 (bd, 1H, JHH
= 7.5 Hz), 6.85−7.00 (m, 4H), 7.01 (bt, 1H, JHH = 7.5 Hz), 7.05−
7.15 (m, 3H), 7.18 (bt, 1H, JHH = 7.5 Hz), 7.44 (d, 1H, JHH = 7.7
Hz), 7.49 (d, 1H, JHH = 5.7 Hz), 7.60−7.70 (m, 4H), 7.82 (d, 2H, JHH
= 7.0 Hz), 7.95 (d, 1H, JHH = 5.7 Hz), 8.04 (dt, 1H, JHH = 7.9 Hz, JHH
= 1.4 Hz), 8.32 (d, 1H, JHH = 8.2 Hz). 13C NMR (150 MHz, CDCl3)
δ: 39.4 (CH3), 56.1 (CH2), 118.9 (CH), 119.3 (CH), 121.0 (CH),
122.3 (CH), 122.6 (CH), 122.7 (CH), 123.6 (CH), 124.5 (CH),
124.5 (CH), 125.7 (CH), 126.8 (CH), 128.0 (CH), 128.4 (CH),
130.1 (CH), 130.6 (CH), 131.1 (CH), 131.3 (CH), 134.3 (C), 136.3
(CH), 137.4 (CH), 139.8 (CH), 142.6 (C), 144.4 (C), 148.0 (CH),
148.8 (C), 149.7 (C), 150.3 (C), 152.1 (CH), 153.9 (CH), 164.9
(C), 167.2 (C), 168.7 (C), 171.4 (C). 19F NMR (564.3 MHz,
CDCl3) δ: −153.22 (s). HRMS (ESI-QTOF) ([M]+): m/z calcd for
C37H30IrN6: 749,2132; found: 749,2115.
= 8.0, 1H), 7.66−7.60 (m, 3H), 7.47 (ddd, JHH = 0.8, JHH = 4.8, JHH
=
8.0, 1H), 4.79 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 149.6 (CH),
142.6 (C), 141.9 (C), 138.5 (CH), 134.6 (C), 132.1 (CH), 130.5
(CH), 127.6 (CH), 126.0 (CH), 125.9 (CH), 121.3 (CH), 41.8
(CH3). 19F NMR (376.25 MHz, CDCl3) δ −78.4 (s). HRMS (ESI-
QTOF) ([M]+): m/z calcd for [C14H13N4]+ 237,1135; found:
237.1139
Synthesis of 1-Phenyl-3-methyl-4-(pyridin-2-yl)-1H-1,2,3-triazol-
3-ium Iodide 10b-I and 2-(1-Phenyl-1H-1,2,3-triazol-4-yl)-1-meth-
ylpyridin-1-ium Iodide 11b-I. 2-(1-Phenyl-1H-1,2,3-triazol-4-yl)
pyridine 9b (444 mg, 2.00 mmol) was dissolved in anhydrous ACN
(12 mL), and MeI (0.624 mL, 10.00 mmol, 5 equiv) was added. The
solution was refluxed for 24 h under N2; the solvent was removed, and
the crude was purified by column chromatography on silica gel with
DCM/MeOH = 9/1 as eluent to give 10b-I (95 mg, 0.26 mmol, 13%
yields). 1H NMR (600 MHz, CD3CN) δ: 4.67 (s, 3H), 7.60−7.65 (m,
1H), 7.75−7.80 (m, 3H), 8.00−8.05 (m, 2H), 8.10−8.15 (m, 2H),
8.86 (bt, 1H, JHH = 4.9 Hz), 9.47 (s, 1H). 13C NMR, (CD3CN, 100
−
[Ir(ppy)2(ptp)]+BF4 (2-BF4). From triazolium triflate 10b-OTf 50
mg, 0.06 mmol, yields = 76%. From triazolium iodide 10b-I 42 mg,
J
Inorg. Chem. XXXX, XXX, XXX−XXX